Sam Kulkarni takes the helm at CRISPR Therapeutics as founding CEO steps down – Endpoints News
Endpoints News |
Sam Kulkarni takes the helm at CRISPR Therapeutics as founding CEO steps down
Endpoints News After steering CRISPR Therapeutics to an IPO last year as the last of the big three gene editing companies to make the leap into the public markets, founding CEO Rodger Novak is stepping down and handing the reins over to the original chief business … CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer Somewhat Favorable News Coverage Somewhat Unlikely to Impact CRISPR THERAPTC (CRSP) Share Price Equity Research Analyst's Stock Ratings: TiVo Corporation (TIVO), CRISPR Therapeutics AG (CRSP) |
